Analysis

RELX Delivers Strong 2025 Results with 7% Underlying Revenue Growth, Eyes Robust 2026 Expansion

RELX Delivers Strong 2025 Results with 7% Underlying Revenue Growth, Eyes Robust 2026 Expansion

RELX (NYSE: RELX), the global provider of information-based analytics and decision tools, reported solid full-year 2025 performance. Underlying revenue grew…

Himax Technologies Ends 2025 on Steady Footing as Automotive and AI Demand Support Q4 Performance

Himax Technologies, Inc. (NASDAQ: HIMX) reported steady fourth-quarter fiscal 2025 results, with revenue growth, stable margins, and earnings at the…

Avient Powers Through 2025 on Non-PFAS Innovation and SEM Momentum, Sets Sights on 2026 Growth

Avient Corporation (NYSE: AVNT) is a specialty materials company supplying advanced engineered polymers, colorants and additives to packaging, consumer, healthcare,…

ECARX Returns to Profit, Eyes $1B Revenue in 2026

ECARX Holdings Inc (NASDAQ: ECX), a Chinese automotive technology company providing vehicle computing platforms, digital cockpits, and software for OEMs,…

Tyler Technologies Shares Slide After Fourth-Quarter Results

Tyler Technologies, Inc (NYSE: TYL) shares fell sharply Thursday after the company reported fiscal fourth-quarter 2025 results that missed consensus…

A look at the two key pillars of Hasbro’s (HAS) growth strategy

Shares of Hasbro, Inc. (NASDAQ: HAS) were down over 3% on Thursday. The stock has gained 29% in the past…

Crocs Sees International Demand Surge

Executive Summary Crocs, Inc., the casual-footwear maker known for its comfortable clog designs, concluded FY2025 with stronger than expected fourth…

Zebra Technologies Shares Rise After Q4 2025 Results

Shares of Zebra Technologies Corporation (NASDAQ: ZBRA) rose in active trading on Thursday after the company reported quarterly and annual…

Waters Corporation Shares Fall After Q4 Results and 2026 Sales Guidance

Waters Corporation (NYSE: WAT) shares fell in Thursday trading after the life-science instruments maker reported fourth-quarter 2025 results and issued…

Krystal Biotech: Flawless Vyjuvek Launch

Executive summary Krystal Biotech has successfully transitioned into a commercial-stage biotechnology powerhouse following the landmark regulatory approval and rapid market…